Browse

For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might get the treatment or if there will be enough…

Assessing the health secretary's biggest challenges, and a look at new rules that inject politics into the NIH.

The RNA-focused drugmaker says Inceptive's tools will help prioritize the best development options as well as speed up the research process.